Evofosfamide and Gemcitabine Act Synergistically in Pancreatic Cancer Xenografts by Dual Action on Tumor Vasculature and Inhibition of Homologous Recombination DNA Repair
Y. Otowa, S. Kishimoto, Y. Saida, K. Yamashita, K. Yamamoto, G. V. Chandramouli, N. Devasahayam, J. B. Mitchell, M. C. Krishna, J. R. Brender
This study shows that evofosfamide and gemcitabine work together in pancreatic cancer xenografts by improving tumor oxygenation and inhibiting DNA repair, with effects varying by tumor type.
Antioxidants & Redox Signaling · Sep 1, 2023Peer-reviewedCancer Biology